Stock Taper
SCREENER COMPARE ANY 2 STOCKS
RCEL
AVITA MEDICAL INC.
NASDAQ
$10.35
▲ UP 0.29% (0.03)

KEY STATISTICS

Market Cap$257.12 M
52w High$10.77
52w Low$3.22
Dividend Yield—
Frequency—
P/E-7.19
Volume203.75K
Shares Out.24.84M

COMPANY

LEADERSHIP

Cary G. Vance
CHIEF EXECUTIVE
Cary G. Vance

COMPENSATION 2026

Salary$684,231
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$20,487
Total$3,243,885

ABOUT

SECTOR
Healthcare
WENT PUBLIC
May 14, 2012
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
226

PRICE TARGET

Target High$12.00
Target Low$10.00
Target Median$11.00
Target Consensus$11.00

UPCOMING EARNINGS

DateNov 5, 2026
DayThursday
Rev. Est.$22.35M
NOV
5
THU

SPLIT RECORD

DATETYPERATIO
2020-06-30Reverse1:5
2017-10-17Forward1121:1000
2016-06-21Forward1013:1000

PRICE

$10.35 ▲ UP 0.29% (+$0.03)
OVERLAYS
$10.20$10.35$10.50$10.659:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM10.35

About Avita Medical Inc.

https://avitamedical.com ↗

AVITA Medical Inc. is a regenerative tissue company offering the RECELL System to treat burns, wounds, and dermatological conditions using patient-derived skin cells, with collaborations in cell therapy research.

INDUSTRY

Medical - Devices

A PRODUCT AVITA MEDICAL INC. IS KNOWN FOR

RECELL® System
RECELL® System

The RECELL® System is a medical device that creates a Spray-On Skin™ cell suspension from a small patient skin sample to treat large thermal burns and skin defects, enabling effective healing with minimal donor skin.

COMPETITORS

COMPETITOR
IART COMPARE
MDWD COMPARE
MDXG COMPARE
ORGO COMPARE
SNN COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Recell System$15.43M — $17.12M ▲$19.05M ▲
Lease Revenue$165K $185K ▲$187K ▲$213K ▲

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
UNITED STATES$16.03M $17.1M ▲$18.57M ▲$20.85M ▲
JAPAN$605K $422K ▼$439K ▲$387K ▼
AUSTRALIA$80K $40K ▼$40K $194K ▲
European Union$49K $0 ▼— $182K ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
12
LISTED HERE
2
RANKED BY POSITION SIZE
VTS.AX
0.00% · 958.4K
IWC
0.08% · 109.5K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
100.00%
HOLDERS
109
TOP 12 OF 109 · RANKED BY POSITION SIZE
Orbimed Advisors LLC
41.0M sh · $42.52M
Blackrock Inc.
1.8M sh · $14.13M
Vanguard Group Inc
1.4M sh · $4.98M
Blackrock, Inc.
1.1M sh · $5.82M
Geode Capital Management, LLC
543.0K sh · $2.01M
State Street Corp
429.0K sh · $1.59M
Northern Trust Corp
183.2K sh · $677.77K
Morgan Stanley
157.6K sh · $583.2K
Millennium Management LLC
132.7K sh · $678.14K
Aqr Capital Management LLC
119.3K sh · $609.56K
Bridgeway Capital Management, LLC
118.0K sh · $407.11K
Goldman Sachs Group Inc
116.8K sh · $597.08K

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

★
OFFICER: CFO
O'Toole David D
Purchase · 2.0K shares
2026-06-12
★
OFFICER: CFO
O'Toole David D
Purchase · 2.0K shares
2026-06-12
★
DIRECTOR
Woody Joseph Fralin
Purchase · 5.2K shares
2026-06-09
★
DIRECTOR
Woody Joseph Fralin
Purchase · 5.0K shares
2026-06-09

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 4
4 GRADES IN THE LAST 12 MONTHS
BTIG BUY TD Cowen BUY Lake Street BUY D. Boral Capital BUY

SECTORS PEERS

PEERPRICE
STTK$7.04COMPARE
OVID$2.80COMPARE
LUCD$0.99COMPARE
APYX$3.08COMPARE
VANI$1.42COMPARE
HYPR$0.83COMPARE
NSPR$0.85COMPARE